Xbiome is a developer of microbial pharmaceuticals designed to treat microecological intestinal disorders. Founded by Yan Tan in 2017, Xbiome is backed by Legend Capital, ZhenFund, Gaorong Capital, Primavera Capital Group, and 5Y Capital and is headquartered in Shenzhen.